List of Excipients in API artemether and lumefantrine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing artemether and lumefantrine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | COARTEM | artemether and lumefantrine | 0078-0568 | CELLULOSE, MICROCRYSTALLINE | |
Novartis Pharmaceuticals Corporation | COARTEM | artemether and lumefantrine | 0078-0568 | CROSCARMELLOSE SODIUM | |
Novartis Pharmaceuticals Corporation | COARTEM | artemether and lumefantrine | 0078-0568 | HYPROMELLOSES | |
Novartis Pharmaceuticals Corporation | COARTEM | artemether and lumefantrine | 0078-0568 | MAGNESIUM STEARATE | |
Novartis Pharmaceuticals Corporation | COARTEM | artemether and lumefantrine | 0078-0568 | POLYSORBATE 80 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for artemether and lumefantrine
Excipient focus: CELLULOSE, MICROCRYSTALLINE
artemether and lumefantrine drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | artemether and lumefantrine | 0078-0568 |
Central Texas Community Health Centers | artemether and lumefantrine | 76413-154 |
>Company | >Ingredient | >NDC |
artemether and lumefantrine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
artemether and lumefantrine drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | artemether and lumefantrine | 0078-0568 |
Central Texas Community Health Centers | artemether and lumefantrine | 76413-154 |
>Company | >Ingredient | >NDC |
artemether and lumefantrine drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
artemether and lumefantrine drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Central Texas Community Health Centers | artemether and lumefantrine | 76413-154 |
>Company | >Ingredient | >NDC |
artemether and lumefantrine drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | artemether and lumefantrine | 0078-0568 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
artemether and lumefantrine drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | artemether and lumefantrine | 0078-0568 |
>Company | >Ingredient | >NDC |
artemether and lumefantrine drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Central Texas Community Health Centers | artemether and lumefantrine | 76413-154 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
artemether and lumefantrine drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | artemether and lumefantrine | 0078-0568 |
Central Texas Community Health Centers | artemether and lumefantrine | 76413-154 |
>Company | >Ingredient | >NDC |
artemether and lumefantrine drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
artemether and lumefantrine drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | artemether and lumefantrine | 0078-0568 |
Central Texas Community Health Centers | artemether and lumefantrine | 76413-154 |
>Company | >Ingredient | >NDC |
artemether and lumefantrine drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
artemether and lumefantrine drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | artemether and lumefantrine | 0078-0568 |
Central Texas Community Health Centers | artemether and lumefantrine | 76413-154 |
>Company | >Ingredient | >NDC |
artemether and lumefantrine drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
artemether and lumefantrine drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | artemether and lumefantrine | 0078-0568 |
>Company | >Ingredient | >NDC |
artemether and lumefantrine drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Central Texas Community Health Centers | artemether and lumefantrine | 76413-154 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.